(Q36295162)

13 August 2017

1 reference

title

A survey of antiviral drugs for bioweapons (English)

1 reference

13 August 2017

1 reference

Arthur J Goff

1

1 reference

13 August 2017

Jason Paragas

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2005

1 reference

Antiviral Chemistry & Chemotherapy

13 August 2017

published in

1 reference

13 August 2017

volume

16

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

283-294

1 reference

Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

In vitro evaluation of cyanovirin-N antiviral activity, by use of lentiviral vectors pseudotyped with filovirus envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

S-Adenosyl-L-methionine-dependent macromolecule methyltransferases: potential targets for the design of chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Experimental therapy of filovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Inhibition of arenavirus multiplication in vitro by phenotiazines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

In vitro anti-Junin virus activity of a peptide isolated from Melia azedarach L. leaves

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Antiviral and antimetabolic activities of neplanocins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5'-nor derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

A novel selective broad-spectrum anti-DNA virus agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Broad-spectrum antiviral activity of the carbocyclic analog of 3-deazaadenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Antiviral treatment of Argentine hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Inhibitory effect of thiosemicarbazone derivatives on Junin virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Antiviral and virucidal activities against arenaviruses of zinc-finger active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Differential inhibitory action of two azoic compounds against arenaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Field trials of methisazone as a prophylactic agent against smallpox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Experimental study on the possibility of treatment of some hemorrhagic fevers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

In vitro activity of potential anti-poxvirus agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Enhanced inhibition of orthopoxvirus replication in vitro by alkoxyalkyl esters of cidofovir and cyclic cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Progressive vaccinia treated with ribavirin and vaccinia immune globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Treatment of Bolivian hemorrhagic fever with intravenous ribavirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Treatment of Variola Major with Adenine Arabinoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Lassa fever. Effective therapy with ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

New neplanocin analogues. 7. Synthesis and antiviral activity of 2-halo derivatives of neplanocin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Equine infectious anemia virus and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Synthesis and antiviral properties of (+/-)-5'-noraristeromycin and related purine carbocyclic nucleosides. A new lead for anti-human cytomegalovirus agent design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Ubiquitin is part of the retrovirus budding machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Ubiquitin in avian leukosis virus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Ribavirin effect on experimental Junin virus-induced encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Evaluation of selected chemotypes in coupled cellular and molecular target-based screens identifies novel HIV-1 zinc finger inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Clinical uses of cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

New neplanocin analogues. 6. Synthesis and potent antiviral activity of 6'-homoneplanocin A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

3-deaza- and 7-deaza-5'-noraristeromycin and their antiviral properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

An epimer of 5'-noraristeromycin and its antiviral properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Viral Keratitis-Inhibitory Effect of 9-β- d -Arabinofuranosylhypoxanthine 5′-Monophosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Effect of 1-beta-D-ribofuranosyl1-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on herpes and vaccinia keratitis and encephalitis in laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

A review of compounds exhibiting anti-orthopoxvirus activity in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Stampidine prevents mortality in an experimental mouse model of viral hemorrhagic fever caused by lassa virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Antiviral activity of C-alkylated purine nucleosides obtained by cross-coupling with tetraalkyltin reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Inhibition of factor VIIa/tissue factor with nematode anticoagulant protein c2: from unique mechanism to a promising new clinical anticoagulant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Ubiquitin in retrovirus assembly: actor or bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Effect of ribavirin and immune serum on Junin virus-infected primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Therapeutic effect of the antiviral agent ribavirin in Junín virus infection of primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

Sulfated polysaccharides extracted from sea algae as potential antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

The inhibition of vaccinia virus multiplication by isatin-beta-thiosemicarbazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632020501600501

10.1177/095632020501600501

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference